Ono

ONO adheres to the corporate philosophy of "dedicated to humanity's fight against disease and suffering," striving together to create innovative drugs with global competitiveness. By optimizing our strengths with a forward-looking perspective, we are actively seeking to become a "global niche pharmaceutical company," a research and development-focused global pharmaceutical company specializing in specific fields.ONO is committed to being a leader in drug discovery with certainty and global competitiveness. Leveraging the technologies and expertise cultivated through our research history, we drive drug development in areas where we can continue to optimize our strengths and effectively utilize our genetic assets in the field of genomic medicine. We actively pursue the discovery and development of drugs to meet unmet medical needs at the forefront of healthcare.By strengthening global strategic alliances, we aim to enhance our drug discovery capabilities, introduce groundbreaking drug discovery seeds and cutting-edge technologies from biopharmaceutical companies, and collaborate with academic and other research institutions in Europe and the United States.We continuously expand our development pipeline, directing our efforts towards licensing activities such as the licensing of new drug candidates. In line with this R&D policy, we are committed to enhancing our corporate social value through the continuous development and commercialization of drugs that bring real benefits to patients. With all our strengths, we are prepared and ready to meet the global market.